MA55478A - Inhibiteurs bicycliques de hpk1 - Google Patents
Inhibiteurs bicycliques de hpk1Info
- Publication number
- MA55478A MA55478A MA055478A MA55478A MA55478A MA 55478 A MA55478 A MA 55478A MA 055478 A MA055478 A MA 055478A MA 55478 A MA55478 A MA 55478A MA 55478 A MA55478 A MA 55478A
- Authority
- MA
- Morocco
- Prior art keywords
- bicyclic
- hpk1 inhibitors
- hpk1
- inhibitors
- bicyclic hpk1
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962823712P | 2019-03-26 | 2019-03-26 | |
EP19167828 | 2019-04-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA55478A true MA55478A (fr) | 2022-02-09 |
Family
ID=69845448
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA055478A MA55478A (fr) | 2019-03-26 | 2020-03-24 | Inhibiteurs bicycliques de hpk1 |
Country Status (7)
Country | Link |
---|---|
US (1) | US20220169644A1 (fr) |
EP (1) | EP3947373A1 (fr) |
AU (1) | AU2020249397A1 (fr) |
CA (1) | CA3129772A1 (fr) |
MA (1) | MA55478A (fr) |
TW (1) | TW202102500A (fr) |
WO (1) | WO2020193512A1 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3873608A1 (fr) | 2018-10-31 | 2021-09-08 | Gilead Sciences, Inc. | Composés 6-azabenzimidazole substitués ayant une activité inhibitrice de hpk1 |
CA3117556A1 (fr) | 2018-10-31 | 2020-05-07 | Gilead Sciences, Inc. | Composes de 6-azabenzimidazole substitues en tant qu'inhibiteurs de hpk1 |
TWI826690B (zh) | 2019-05-23 | 2023-12-21 | 美商基利科學股份有限公司 | 經取代之烯吲哚酮化物及其用途 |
WO2022184152A1 (fr) * | 2021-03-03 | 2022-09-09 | 劲方医药科技(上海)有限公司 | Composé hétérocyclique à six chaînons substitué par un cycle condensé, son procédé de préparation et son utilisation |
EP4353721A1 (fr) * | 2021-05-11 | 2024-04-17 | Evopoint Biosciences Co., Ltd. | Composé hétérocyclique contenant de l'azote |
TW202321239A (zh) | 2021-07-20 | 2023-06-01 | 瑞典商阿斯特捷利康公司 | 作為hpk1抑制劑用於治療癌症之經取代的吡𠯤—2—甲醯胺 |
CN113861188B (zh) * | 2021-08-23 | 2023-02-28 | 杭州医学院 | 吡唑并[3,4-b]吡啶类衍生物及其制备方法和作为HPK1抑制剂的应用 |
CA3233233A1 (fr) * | 2021-10-15 | 2023-04-20 | Ruben Abagyan | 1h-pyrazolo[4,3-c]quinoleines substituees, leurs procedes de preparation et leur utilisation |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3227337A1 (fr) | 2014-12-05 | 2017-10-11 | F. Hoffmann-La Roche AG | Procédés et compositions de traitement du cancer à l'aide d'antagonistes de l'axe pd-1 et d'antagonistes de hpk1 |
EP3322711B1 (fr) | 2015-06-25 | 2021-03-10 | University Health Network | Inhibiteurs de hpk1 et leurs procédés d'utilisation |
WO2018049191A1 (fr) | 2016-09-09 | 2018-03-15 | Incyte Corporation | Dérivés de pyrazolopyridone en tant que modulateurs de hpk1 et leurs utilisations pour le traitement du cancer |
TW201811799A (zh) | 2016-09-09 | 2018-04-01 | 美商英塞特公司 | 吡唑并嘧啶化合物及其用途 |
EP4119558A1 (fr) | 2016-09-09 | 2023-01-18 | Incyte Corporation | Composés de pyrazolopyridine et leurs utilisations |
WO2018049214A1 (fr) | 2016-09-09 | 2018-03-15 | Incyte Corporation | Dérivés de pyrazolopyridine comme modulateurs de hpk1 et leurs utilisations pour le traitement du cancer |
WO2018081531A2 (fr) | 2016-10-28 | 2018-05-03 | Ariad Pharmaceuticals, Inc. | Méthodess d'activation de lymphocytes t humains |
WO2018102366A1 (fr) | 2016-11-30 | 2018-06-07 | Ariad Pharmaceuticals, Inc. | Anilinopyrimidines en tant qu'inhibiteurs de kinase 1 progénitrices hématopoïétiques (hpk1) |
EP3596075B1 (fr) | 2017-03-15 | 2023-10-11 | F. Hoffmann-La Roche AG | Azaindoles utilisés en tant qu'inhibiteurs de hpk1 |
BR112019018093A2 (pt) | 2017-03-30 | 2020-06-16 | F. Hoffmann-La Roche Ag | Compostos, composição, método de inibição de hpk1, métodos para melhorar uma resposta imune e para tratar um distúrbio e usos do composto |
MX2019010302A (es) | 2017-03-30 | 2019-11-21 | Hoffmann La Roche | Isoquinolinas como inhibidores de hpk1. |
CN112601752A (zh) | 2017-05-26 | 2021-04-02 | 伊克诺斯科学公司 | Map4k1的新颖抑制剂 |
WO2018228925A1 (fr) | 2017-06-13 | 2018-12-20 | Bayer Pharma Aktiengesellschaft | Dérivés de pyrrolopyridine substitués |
WO2018228923A1 (fr) | 2017-06-13 | 2018-12-20 | Bayer Pharma Aktiengesellschaft | Dérivés de pyrrolopyridine substitués utilisés en tant que modulateurs de map4k1 pour le traitement de maladies cancéreuses |
CA3066859A1 (fr) | 2017-06-13 | 2018-12-20 | Bayer Pharma Aktiengesellschaft | Derives de pyrrolopyridine substitues |
WO2019051199A1 (fr) | 2017-09-08 | 2019-03-14 | Incyte Corporation | Composés de 6-cyano-indazole utilisés en tant que modulateurs de kinase 1 progénitrices hématopoïétiques (hpk1) |
-
2020
- 2020-03-24 US US17/442,655 patent/US20220169644A1/en active Pending
- 2020-03-24 CA CA3129772A patent/CA3129772A1/fr active Pending
- 2020-03-24 EP EP20711974.4A patent/EP3947373A1/fr active Pending
- 2020-03-24 WO PCT/EP2020/058085 patent/WO2020193512A1/fr unknown
- 2020-03-24 MA MA055478A patent/MA55478A/fr unknown
- 2020-03-24 TW TW109109736A patent/TW202102500A/zh unknown
- 2020-03-24 AU AU2020249397A patent/AU2020249397A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US20220169644A1 (en) | 2022-06-02 |
WO2020193512A1 (fr) | 2020-10-01 |
EP3947373A1 (fr) | 2022-02-09 |
AU2020249397A1 (en) | 2021-09-30 |
TW202102500A (zh) | 2021-01-16 |
CA3129772A1 (fr) | 2020-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA54543A (fr) | Inhibiteurs de kif18a | |
DK3873903T3 (da) | Substituerede 6-azabenzimidazolforbindelser som hpk1-hæmmere | |
MA55478A (fr) | Inhibiteurs bicycliques de hpk1 | |
MA54550A (fr) | Inhibiteurs de kif18a | |
MA52413A (fr) | Inhibiteurs de cd73 | |
IL292116A (en) | Bicyclic amines as cdk2 repressors | |
AR119765A1 (es) | Compuestos de imidazolil pirimidinilamina como inhibidores de cdk2 | |
MA52812A (fr) | Inhibiteurs de sarm1 | |
MA44006A (fr) | Inhibiteur pde1 | |
MA55477A (fr) | Inhibiteurs de hpk1 | |
MA47301A (fr) | Inhibiteurs sélectifs de jak1 | |
MA55909A (fr) | Inhibiteurs de cdk | |
MA51611A (fr) | Inhibiteurs de pi4kiiibêta | |
MA52813A (fr) | Inhibiteurs de sarm1 | |
MA53841A (fr) | Inhibiteurs pde9 de pyrazolopyrimidine | |
DK3519419T3 (da) | Beta-lactamase-inhibitorer | |
MA52809A (fr) | Inhibiteurs de sarm1 | |
DK3738452T3 (da) | Fordamper | |
KR20220035377A (ko) | 람노오스-다당류 | |
DE112020005796A5 (de) | Spannfutter | |
ES1239439Y (es) | Torno trepanador | |
ES1243687Y (es) | Salmorejo | |
IT201900020430A1 (it) | Espositore | |
DE202019004111U8 (de) | Weichenstellvorichtung | |
TH190914S (th) | ขันโตก |